Jaundice during cyproheptadine treatment.
D000328:Adult; D002779:Cholestasis / Q000139:chemically induced; D003533:Cyproheptadine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007565:Jaundice / Q000139:chemically induced*; D011537:Pruritus / Q000188:drug therapy
D003533:Cyproheptadine